Details
New companies 2 · Follow-on 0
Stages: Series C+ 2
Horizon3 $250M Series EIterative Health $77M Series CRanked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Series C+ 2
Horizon3 $250M Series EIterative Health $77M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Olix $312M Series BOXMIQ Labs $35M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Olix $312M Series BWaypoint Bio $20M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Horizon3 $250M Series EArmada $230M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Horizon3 $250M Series EHavoc $100M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Balance Theory $19M Series AKnowledgeNet.ai $500K SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Cantina $8M UndisclosedMidas $50M Series ANew companies 2 · Follow-on 0
Stages: Growth 1, Undisclosed 1
Xsight Labs >$300M GrowthLyte $107M UndisclosedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Lydian $43M Series AMoment Energy >$40M Series BNew companies 2 · Follow-on 0
Stages: Series B 2
Provable Markets Undisclosed Series BWealth.com $65M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
ThreatLocker $190M Series FTekst €11.5M Series ANew companies 2 · Follow-on 0
Stages: Series A 2
Terminal $20M Series ADominion Dynamics CA$139M Series ANew companies 2 · Follow-on 0
Stages: Growth 1, Series B 1
Precise Behavioral $14.2M GrowthGreater Good Health $20.5M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Qureight $20M Series BKord £6.4M Series ANew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Qureight $20M Series BSatVu £30M Series ANew companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
CopySight $3M SeedHandl Health $14.2M Series A“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.